[Digestive polyposis. Retrospective study of 20 cases]
Samia Chatti-Dey1, Leila Bacha, Essia Saiji
1Service d'Anatomie et de Cytologie Pathologiques, Hôpital MT Maamouri de Nabeul, route de Mrezka, Nabeul, Tunisie.
La Tunisie Medicale
|December 11, 2007
Summary
Familial adenomatous polyposis (FAP) management was evaluated in 20 patients. 11 cases of colonic adenocarcinoma were found in FAP patients, highlighting the 100% risk of colon cancer.
Area of Science:
- Gastroenterology
- Oncology
- Genetics
Context:
- Digestive polyposis syndromes, including familial adenomatous polyposis (FAP), juvenile polyposis syndrome (JPS), and Peutz-Jeghers syndrome, are autosomal dominant disorders.
- A study was conducted at MT Maarmouri's Hospital, Nabeul city, involving 20 patients from pathology, surgery, and gastroenterology departments.
Purpose:
- To evaluate the management of digestive polyposis.
- To analyze the clinical presentation and outcomes of patients with FAP, JPS, and Peutz-Jeghers syndrome.
Summary:
- The study identified 15 cases of adenomatous polyposis, including 2 family groups, 3 members with JPS, and 2 cases of Peutz-Jeghers syndrome.
- Out of 15 adenomatous polyposis patients, 11 had colonic adenocarcinoma. FAP is characterized by extensive colorectal involvement and extra-colonic manifestations, carrying a 100% risk of colon cancer.
- JPS involves numerous juvenile polyps, typically before age 20, with a low risk of cancer progression. Peutz-Jeghers syndrome presents with hamartomatous polyps, pigmentation, and increased risk of extradigestive cancers.
Impact:
- This study underscores the critical importance of early detection and management of FAP due to its high risk of colorectal cancer.
- Understanding the distinct characteristics of FAP, JPS, and Peutz-Jeghers syndrome aids in tailored patient care and risk stratification.
- The findings contribute to the clinical knowledge base for managing hereditary polyposis syndromes and their associated oncological risks.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...

